{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:33:36Z","timestamp":1781566416029,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,10]]},"DOI":"10.7759\/cureus.34828","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T12:30:23Z","timestamp":1676032223000},"source":"Crossref","is-referenced-by-count":1,"title":["Thymoma and Myasthenia Gravis: An Examination of a Paraneoplastic Manifestation"],"prefix":"10.7759","author":[{"given":"Mira","family":"Itani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarden","family":"Goldman Gollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Ezell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mohanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caoimhin","family":"Mears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina A","family":"Mears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Feinsilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina","family":"Nahleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-013-9564-5","article-title":"Thymus and aging: morphological, radiological, and functional overview","volume":"36","author":"Rezzani R","year":"2014","unstructured":"Rezzani R, Nardo L, Favero G, Peroni M, Rodella LF. Thymus and aging: morphological, radiological, and functional overview. Age (Dordr). 2014, 36:313-51. 10.1007\/s11357-013-9564-5","journal-title":"Age (Dordr)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00897","article-title":"Postnatal involution and counter-involution of the thymus","volume":"11","author":"Cowan JE","year":"2020","unstructured":"Cowan JE, Takahama Y, Bhandoola A, Ohigashi I. Postnatal involution and counter-involution of the thymus. Front Immunol. 2020, 11:897. 10.3389\/fimmu.2020.00897","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors?","volume":"17","author":"Marx A","year":"2022","unstructured":"Marx A, Chan JK, Chalabreysse L, et al.. The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors?. J Thorac Oncol. 2022, 17:200-13. 10.1016\/j.jtho.2021.10.010","journal-title":"J Thorac Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1374","article-title":"Polyparaneoplastic manifestations of malignant thymoma: a unique case of myasthenia, autoimmune hepatitis, pure red cell aplasia, and keratoconjunctivitis sicca","volume":"9","author":"Feinsilber D","year":"2017","unstructured":"Feinsilber D, Mears KA, Pettiford BL. Polyparaneoplastic manifestations of malignant thymoma: a unique case of myasthenia, autoimmune hepatitis, pure red cell aplasia, and keratoconjunctivitis sicca. Cureus. 2017, 9:e1374. 10.7759\/cureus.1374","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000215","article-title":"Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma","volume":"9","author":"Safieddine N","year":"2014","unstructured":"Safieddine N, Liu G, Cuningham K, et al.. Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma. J Thorac Oncol. 2014, 9:1018-22. 10.1097\/JTO.0000000000000215","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels EA","year":"2010","unstructured":"Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010, 5:S260-5. 10.1097\/JTO.0b013e3181f1f62d","journal-title":"J Thorac Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms","volume":"6","author":"Detterbeck FC","year":"2011","unstructured":"Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran C. The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol. 2011, 6:S1710-6. 10.1097\/JTO.0b013e31821e8cff","journal-title":"J Thorac Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.11.118","article-title":"Paraneoplastic syndromes and thymic malignancies: an examination of the International thymic malignancy interest group retrospective database","volume":"13","author":"Padda SK","year":"2018","unstructured":"Padda SK, Yao X, Antonicelli A, et al.. Paraneoplastic syndromes and thymic malignancies: an examination of the International thymic malignancy interest group retrospective database. J Thorac Oncol. 2018, 13:436-46. 10.1016\/j.jtho.2017.11.118","journal-title":"J Thorac Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0603","article-title":"Frequency of synaptic autoantibody accompaniments and neurological manifestations of thymoma","volume":"73","author":"Zekeridou A","year":"2016","unstructured":"Zekeridou A, McKeon A, Lennon VA. Frequency of synaptic autoantibody accompaniments and neurological manifestations of thymoma. JAMA Neurol. 2016, 73:853-9. 10.1001\/jamaneurol.2016.0603","journal-title":"JAMA Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer N","year":"2016","unstructured":"Melzer N, Ruck T, Fuhr P, et al.. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016, 263:1473-94. 10.1007\/s00415-016-8045-z","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr AS","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010, 10:46. 10.1186\/1471-2377-10-46","journal-title":"BMC Neurol"},{"key":"ref12","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) - Thymomas and Thymic Carcinomas. (2022). Accessed. November 8, 2022: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.04.95","article-title":"Myasthenia gravis as a prognostic marker in patients with thymoma","volume":"10","author":"Cacho-D\u00edaz B","year":"2018","unstructured":"Cacho-D\u00edaz B, Salmer\u00f3n-Moreno K, Lorenzana-Mendoza NA, Texcocano J, Arrieta O. Myasthenia gravis as a prognostic marker in patients with thymoma. J Thorac Dis. 2018, 10:2842-8. 10.21037\/jtd.2018.04.95","journal-title":"J Thorac Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli MN","year":"2012","unstructured":"Meriggioli MN, Sanders DB. Muscle autoantibodies in myasthenia gravis: beyond diagnosis?. Expert Rev Clin Immunol. 2012, 8:427-38. 10.1586\/eci.12.34","journal-title":"Expert Rev Clin Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071537","article-title":"Drugs that induce or cause deterioration of myasthenia gravis: an update","volume":"10","author":"Sheikh S","year":"2021","unstructured":"Sheikh S, Alvi U, Soliven B, Rezania K. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med. 2021, 10:1537. 10.3390\/jcm10071537","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2019.1643220","article-title":"Uncontrolled recurrent myasthenia gravis exacerbations secondary to chronic gabapentin use","volume":"9","author":"Chien JL","year":"2019","unstructured":"Chien JL, Baez V, Mody HR. Uncontrolled recurrent myasthenia gravis exacerbations secondary to chronic gabapentin use. J Community Hosp Intern Med Perspect. 2019, 9:371-2. 10.1080\/20009666.2019.1643220","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/BF02913506","article-title":"Measurement of antiacetylcholine receptor antibody in patients with thymoma without myasthenia gravis complications","volume":"49","author":"Sakuraba M","year":"2001","unstructured":"Sakuraba M, Onuki T, Nitta S. Measurement of antiacetylcholine receptor antibody in patients with thymoma without myasthenia gravis complications. Jpn J Thorac Cardiovasc Surg. 2001, 49:690-2. 10.1007\/BF02913506","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21037\/med.2018.AB011","article-title":"The importance of measuring acetylcholine receptor antibodies in thymomas","volume":"2","author":"Marcuse F","year":"2018","unstructured":"Marcuse F, Hochstenbag M, Hoeijmakers J, Maessen J, De Baets M. The importance of measuring acetylcholine receptor antibodies in thymomas. Mediastinum. 2018, 2:AB011. 10.21037\/med.2018.AB011","journal-title":"Mediastinum"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/gs-21-287","article-title":"Relationship between anti-acetylcholine receptor antibodies and the development of post-thymectomy myasthenia gravis in patients with thymoma: a single-center experience","volume":"10","author":"Nabe Y","year":"2021","unstructured":"Nabe Y, Hashimoto T, Tanaka K, et al.. Relationship between anti-acetylcholine receptor antibodies and the development of post-thymectomy myasthenia gravis in patients with thymoma: a single-center experience. Gland Surg. 2021, 10:2408-13. 10.21037\/gs-21-287","journal-title":"Gland Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002275","article-title":"Plasma exchange for myasthenia gravis","volume":"2002","author":"Gajdos P","year":"2002","unstructured":"Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev. 2002, 2002:CD002275. 10.1002\/14651858.CD002275","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/124855-thymoma-and-myasthenia-gravis-an-examination-of-a-paraneoplastic-manifestation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:47Z","timestamp":1707508727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/124855-thymoma-and-myasthenia-gravis-an-examination-of-a-paraneoplastic-manifestation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.34828","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}